R&D Beyond GLP-1: Preclinical hurdles and solutions for next-gen... The development experience with GLP-1 analogues offers critical insights for navigating ADME challenges in contemporary peptide programmes.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.